Immunotec Inc.
TSX VENTURE : IMM

Immunotec Inc.

February 25, 2014 16:05 ET

Immunotec Announces Completion of its International Convention in Mexico City

1,500 Consultants celebrating Culture and Field Accomplishments.

VAUDREUIL-DORION, QUEBEC--(Marketwired - Feb. 25, 2014) - Immunotec Inc. (TSX VENTURE:IMM), a Canadian based company and a leader in the wellness industry (the "Company") today announces the completion of its International Convention held from February 20 to 22, 2014 at the Expo Bancomer Convention Center in Santa Fe, Mexico. Under the theme One Vision, One Team, nearly 1,500 independent Consultants participated in celebrating the Immunotec heritage of developing innovative products while being recognized for their accomplishments over the past year.

"This event was a success surpassing previous Convention attendee counts and a testimony of our performance in Mexico," said Mr. Charles L. Orr, Chief Executive Officer." This platform also launched our new plans for 2014. The new programs are designed to support our Field in achieving future growth as we are preparing to leverage the content and excitement of this Convention on a road tour in many cities starting March 15th in Montreal, Toronto, Orlando, Los Angeles and more to come."

"Many of our independent Consultants experienced growth in building their businesses during 2013. This has enabled them to advance in rank while developing their businesses across our network and markets," said JP Trottier, Immunotec's Vice-President of Business Development. "The 2014 Trip Incentive this coming November was launched and everybody committed to reach new heights and qualify to attend."

About Immunotec Inc.

Immunotec Inc. is dedicated to making a positive difference in people's lifestyle every day by offering research-driven nutritional products through its network of Independent Consultants worldwide. Immunotec's strength comes from its culture that emphasizes teamwork and entrepreneurial leadership by employees, consultants and research collaborators.

Headquartered with manufacturing facilities near Montreal, Canada, Immunotec Consultants generate nearly $55.0 Million in annual revenues. Please visit us at www.immunotec.com for additional information.

The Company files its consolidated financial statements, its management and discussion analysis report, its press releases and such other required documents on the SEDAR database at www.sedar.com and on the Company's website at www.immunotec.com. The common shares of the Company are listed on the TSX Venture Exchange under the ticker symbol IMM. Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

CAUTION REGARDING FORWARD-LOOKING STATEMENTS: Certain statements contained in this news release are forward looking and are subject to numerous risks and uncertainties, known and unknown. For information identifying known risks and uncertainties and other important factors that could cause actual results to differ materially from those anticipated in the forward-looking statements, please refer to the heading Risks and Uncertainties in Immunotec's most recent Management's Discussion and Analysis, which can be found at www.sedar.com. Consequently, actual results may differ materially from the anticipated results expressed in these forward-looking statements.

Contact Information

  • Patrick Montpetit CPA, CA, CF
    Vice-President and Chief Financial Officer
    Immunotec Inc.
    (450) 510-4527